Christopher M. Jenner
FDA Investigator
- Christopher M. Jenner first started conducting FDA inspections in 2017, with the last inspection in 2022. Over that time, Christopher M. Jenner has conducted 52 inspections at 48 companies across 48 sites.
Get Christopher Jenner's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Broncolin, S.A. de C.V., Ciudad De Mexico | 2022
Out of stock

FDA 483 Grisi Hnos, S.A. de C.V., Ciudad De Mexico | 2022
Out of stock

FDA 483 Zermat Internacional, S.A. de C.V., Tlalnepantla | 2022
Out of stock

FDA 483 RLC Labs Inc., Phoenix | 2021
Out of stock

FDA 483 AniCell Biotech, LLC, Chandler | 2019
Out of stock

FDA 483 AET Laboratories Private Limited, Sangareddy District | 2019
Out of stock

FDA 483 Dermya, Inc. dba Kidskin, Valley Village | 2019
Out of stock

FDA 483 SALUS MEDICAL LLC, Phoenix | 2019
Out of stock

FDA 483 Kleen Concepts, LLC, Scottsdale | 2018
Out of stock

FDA 483 Simple Ideas, Inc, El Mirage | 2018
Out of stock

FDA 483 Azteca Bakeries, Incorporated, Phoenix | 2018
Out of stock

FDA 483 INSYS DEVELOPMENT COMPANY, INC., Chandler | 2018
Out of stock
Co-Investigators (21)
- Tiara M. Brown, FDA Investigator
- Amir Alavi, FDA Investigator
- Michael T. Cyrus, FDA Investigator
- Gunneet Kaur, FDA Investigator
- Alan M. Barker, FDA Investigator
- Carrie A. Hughes, FDA Investigator
- Joey V. Quitania, FDA Investigator
- Zachary A. Bogorad, FDA Investigator
- Nicholas L. Hunt, FDA Investigator
- Lisa M. Schultz, FDA Investigator
- Diane R. Weidley, FDA Investigator
- Santiago Gallardo Johnson, FDA Investigator
- Zachery L. Miller, FDA Investigator
- Walden H. Lee, FDA Investigator
- Amanda L. Fyles, FDA Investigator
- Kristin M. Abaonza, FDA Investigator
- Zachary L. Stamm, FDA Investigator
- Jacob W. Reynolds, FDA Investigator
- Nayan J. Patel, FDA Investigator
- Laura A. Munsterman, FDA Investigator
- James P. Stallings, FDA Investigator
